About the Authors

Alexandra U. Scherrer

alexandra.scherrer@usz.ch

Affiliation Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zürich, University of Zürich, Zürich, Switzerland

Bruno Ledergerber

Affiliation Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zürich, University of Zürich, Zürich, Switzerland

Viktor von Wyl

Affiliation Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zürich, University of Zürich, Zürich, Switzerland

Jürg Böni

Affiliation Institute of Medical Virology, Swiss National Center for Retroviruses, University of Zürich, Zürich, Switzerland

Sabine Yerly

Affiliation Laboratory of Virology, Geneva University Hospitals, Geneva, Switzerland

Thomas Klimkait

Affiliation Institute for Medical Microbiology, University of Basel, Basel, Switzerland

Cristina Cellerai

Affiliation Division of Immunology and Allergy, University Hospital Lausanne, Lausanne, Switzerland

Hansjakob Furrer

Affiliation Division of Infectious Diseases, University Hospital Berne, University of Berne, Berne, Switzerland

Alexandra Calmy

Affiliation Division of Infectious Diseases, University Hospitals Geneva, Geneva, Switzerland

Matthias Cavassini

Affiliation Infectious Diseases Service, University Hospital Lausanne, Lausanne, Switzerland

Luigia Elzi

Affiliation Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland

Pietro L. Vernazza

Affiliation Division of Infectious Diseases, Cantonal Hospital St. Gallen, St. Gallen, Switzerland

Enos Bernasconi

Affiliation Division of Infectious Diseases, Regional Hospital Lugano, Lugano, Switzerland

Huldrych F. Günthard

Affiliation Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zürich, University of Zürich, Zürich, Switzerland

and the Swiss HIV Cohort Study (SHCS)

Membership of the Swiss HIV Cohort Study is provided in the Acknowledgments.

Competing Interests

The authors have the following interests: HFG has been an adviser and/or consultant for the following companies: GlaxoSmithKline, Abbott, Novartis, Boehringer Ingelheim, Roche, Tibotec and Bristol-Myers Squibb, and has received unrestricted research and educational grants from Roche, Abbott, Bristol-Myers Squibb, GlaxoSmithKline, Gilead, Tibotec and Merck Sharp and Dohme (all money went to institution). SY has participated in advisory boards of Bristol-Myers Squibb and Tibotec, and has received travel grants from GlaxoSmithKline and Merck Sharp and Dohme. TK served as advisor for Bristol-Myers Squibb and Pfizer and has received travel grants from Abbott and Pfizer. This study was funded by a research grant from the Union Bank of Switzerland in the name of a donor to HFG, an unrestricted research grant from Tibotec, Switzerland to HFG and from Gilead, Switzerland to HFG. There are no patents, products in development or marketed products to declare. This does not alter the authors’ adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.

Author Contributions

Performed the experiments: JB SY CC TK. Analyzed the data: AUS VvW BL. Contributed reagents/materials/analysis tools: HFG AC MC LE PLV EB HF. Wrote the paper: AUS HFG.